{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:24:18Z","timestamp":1793168658332,"version":"4.5.0"},"reference-count":51,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Health care use increases before multiple sclerosis (MS) onset. However, most studies have focused on the 5 to 10 years preceding the first demyelinating disease code from administrative data. Few studies have examined patterns before clinically determined MS symptom onset from clinical records.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine health care use 25 years before MS symptom onset in a clinical cohort from British Columbia, Canada.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This matched cohort study accessed data prospectively collected from January 1991 to September 2018. All data were released mid-2024 for analysis. The study was conducted in British Columbia using publicly funded universal health insurance data. Patients with MS were identified from MS clinic records and matched with up to 5 individuals randomly selected without replacement from the general population by sex, birth year, socioeconomic status, and postal code of residency.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n \n Linked clinical and administrative data were used to compare physician visit rates 25 years before MS onset using adjusted negative binomial models and 15 years before MS onset by\n International Classification of Diseases, Ninth Revision<\/jats:italic>\n (\n ICD-9<\/jats:italic>\n ) chapter and physician specialty.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 2038 patients with MS (mean [SD] age at symptom onset, 37.9 [10.9] years; 1508 female [74.0%]) and 10 182 matched individuals were included. All-cause physician visit rate ratios (RRs) for patients with MS were consistently elevated from 14 years before onset (adjusted RR [ARR], 1.19; 95% CI, 1.07-1.33), peaking the year before MS onset (ARR, 1.28; 95% CI, 1.21-1.35). The RRs for ill-defined symptoms and signs were consistently elevated 15 years before onset, exceeding 1.15 and peaking at 1.47 (95% CI, 1.36-1.58) the year before MS onset. Mental health\u2013related RRs from 14 years before onset were significant (excluding years 7, 5, and 4), with RRs in the 3 years before MS onset ranging from 1.30 (95% CI, 1.05-1.58) to 1.38 (95% CI, 1.12-1.68). Sensory, musculoskeletal, and nervous system RRs were elevated 8, 5, and 4 years before onset, respectively, with, for example, a peak of 2.42 (95% CI, 1.90-3.07) for nervous system concerns the year before MS onset. By physician specialty, general practice visit RRs were significantly elevated in each of the 15 years before MS onset, reaching 1.23 (95% CI, 1.17-1.30) in the year before onset. Psychiatry visit RRs were elevated 12 years before onset (2.59; 95% CI, 1.23-5.47). Neurology and ophthalmology RRs were significantly higher up to 8 to 9 years before onset, peaking the year before MS onset at 5.46 (95% CI, 4.30-6.93) for neurology and 1.64 (95% CI, 1.30-2.08) for ophthalmology.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this matched cohort study of people with and without MS, health care use was higher among patients with MS 14 to 15 years before MS symptom onset, suggesting that MS may have started earlier than previously thought. Mental health and psychiatric issues along with ill-defined signs and symptoms might be among the earliest features of the prodromal period preceding nervous system\u2013related and neurologic visits by 7 to 11 years.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.24635","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T15:30:35Z","timestamp":1754062235000},"page":"e2524635","source":"Crossref","is-referenced-by-count":15,"title":["Health Care Use Before Multiple Sclerosis Symptom Onset"],"prefix":"10.1001","volume":"8","author":[{"given":"Marta","family":"Ruiz-Alguer\u00f3","sequence":"first","affiliation":[{"name":"Faculty of Medicine (Neurology), University of British Columbia and The Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine (Neurology), University of British Columbia and The Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anibal","family":"Chertcoff","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (Neurology), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinshan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Faculty of Medicine (Neurology), University of British Columbia and The Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (Neurology), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada"},{"name":"Department of Medicine and Community Health and Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Nova Scotia Health, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Tremlett","sequence":"additional","affiliation":[{"name":"Faculty of Medicine (Neurology), University of British Columbia and The Djavad Mowafaghian Centre for Brain Health, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"3","key":"zoi250702r1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neurol.2023.07.002","article-title":"Prodromes in demyelinating disorders, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer\u2019s dementia.","volume":"180","author":"Marrie","year":"2024","journal-title":"Rev Neurol (Paris)"},{"issue":"10","key":"zoi250702r2","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1093\/brain\/awac185","article-title":"Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity.","volume":"145","author":"Benatar","year":"2022","journal-title":"Brain"},{"key":"zoi250702r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105279","article-title":"Characterising the prodromal phase in dementia with Lewy bodies.","volume":"107","author":"Mellergaard","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"issue":"September","key":"zoi250702r4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1232387","article-title":"Identifying prodromal symptoms at high specificity for Parkinson\u2019s disease.","volume":"15","author":"Jackson","year":"2023","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"zoi250702r5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/acn3.51945","article-title":"Gastrointestinal conditions in the multiple sclerosis prodrome.","volume":"11","author":"Yusuf","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"zoi250702r6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1177\/1352458518783662","article-title":"Five years before multiple sclerosis onset: phenotyping the prodrome.","volume":"25","author":"Wijnands","year":"2019","journal-title":"Mult Scler"},{"issue":"6","key":"zoi250702r7","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1474-4422(17)30076-5","article-title":"Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.","volume":"16","author":"Wijnands","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi250702r8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/acn3.52267","article-title":"Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex.","volume":"12","author":"Tremlett","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"zoi250702r9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1177\/1352458513477924","article-title":"Fatigue heralding multiple sclerosis.","volume":"19","author":"Berger","year":"2013","journal-title":"Mult Scler"},{"issue":"3","key":"zoi250702r10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1352458515588973","article-title":"Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis.","volume":"22","author":"Hoang","year":"2016","journal-title":"Mult Scler"},{"issue":"6","key":"zoi250702r11","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ana.25247","article-title":"Prodromal symptoms of multiple sclerosis in primary care.","volume":"83","author":"Disanto","year":"2018","journal-title":"Ann Neurol"},{"issue":"20","key":"zoi250702r12","doi-asserted-by":"publisher","first-page":"e2026","DOI":"10.1212\/WNL.0000000000207843","article-title":"Psychiatric comorbidity during the prodromal period in patients with multiple sclerosis.","volume":"101","author":"Chertcoff","year":"2023","journal-title":"Neurology"},{"issue":"8","key":"zoi250702r13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/14737175.2020.1746645","article-title":"A systematic review of morbidities suggestive of the multiple sclerosis prodrome.","volume":"20","author":"Yusuf","year":"2020","journal-title":"Expert Rev Neurother"},{"key":"zoi250702r14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1017492","article-title":"Sex and age differences in the multiple sclerosis prodrome.","volume":"13","author":"Yusuf","year":"2022","journal-title":"Front Neurol"},{"issue":"2","key":"zoi250702r15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/1352458520908163","article-title":"Fatigue, sleep disorders, anaemia and pain in the multiple sclerosis prodrome.","volume":"27","author":"Yusuf","year":"2021","journal-title":"Mult Scler"},{"key":"zoi250702r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105775","article-title":"The burden of psychiatric morbidity in multiple sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis.","volume":"89","author":"Tan","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"zoi250702r17","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00415-023-12173-4","article-title":"Prodromal multiple sclerosis: considerations and future utility.","volume":"271","author":"Harding","year":"2024","journal-title":"J Neurol"},{"issue":"2","key":"zoi250702r19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"zoi250702r20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0b013e3181cf6ec0","article-title":"The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"zoi250702r21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics.","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi250702r23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"7","key":"zoi250702r24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/ene.13925","article-title":"Prodrome in relapsing-remitting and primary progressive multiple sclerosis.","volume":"26","author":"Wijnands","year":"2019","journal-title":"Eur J Neurol"},{"issue":"9","key":"zoi250702r25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41582-022-00686-x","article-title":"From the prodromal stage of multiple sclerosis to disease prevention.","volume":"18","author":"Marrie","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"24","key":"zoi250702r26","doi-asserted-by":"publisher","first-page":"e2497","DOI":"10.1212\/WNL.0000000000207981","article-title":"Association between diseases and symptoms diagnosed in primary care and the subsequent specific risk of multiple sclerosis.","volume":"101","author":"Guinebretiere","year":"2023","journal-title":"Neurology"},{"key":"zoi250702r27","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105438","article-title":"Increased healthcare utilization in the year before multiple sclerosis diagnosis.","volume":"83","author":"Razzak","year":"2024","journal-title":"Mult Scler Relat Disord"},{"issue":"6","key":"zoi250702r28","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/acn3.51568","article-title":"Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.","volume":"9","author":"Jons","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"zoi250702r29","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209357","article-title":"Temporal relationship between serum neurofilament light chain and radiologic disease activity in patients with multiple sclerosis.","volume":"102","author":"Fox","year":"2024","journal-title":"Neurology"},{"key":"zoi250702r30","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.3389\/fimmu.2018.03116","article-title":"Pathogenic mechanisms associated with different clinical courses of multiple sclerosis.","volume":"9","author":"Lassmann","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"zoi250702r31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1017\/S2045796017000579","article-title":"Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.","volume":"28","author":"Marrie","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"15","key":"zoi250702r32","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1212\/WNL.0000000000005302","article-title":"Psychiatric comorbidity is associated with disability progression in multiple sclerosis.","volume":"90","author":"McKay","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"zoi250702r33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.7224\/1537-2073.2016-110","article-title":"Diagnoses of depression and anxiety versus current symptoms and quality of life in multiple sclerosis.","volume":"20","author":"Marrie","year":"2018","journal-title":"Int J MS Care"},{"issue":"3","key":"zoi250702r34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.0000000000001718","article-title":"Effect of comorbidity on mortality in multiple sclerosis.","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"zoi250702r35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target.","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"zoi250702r36","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105926","article-title":"Blood brain barrier and inflammation in depression.","volume":"175","author":"Medina-Rodriguez","year":"2022","journal-title":"Neurobiol Dis"},{"issue":"1","key":"zoi250702r37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1474-4422(23)00377-0","article-title":"Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies.","volume":"23","author":"Zierfuss","year":"2024","journal-title":"Lancet Neurol"},{"issue":"5","key":"zoi250702r38","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/acr.25294","article-title":"\u201cWhat came first?\u201d population-based evaluation of health care encounters for depression and anxiety before and after inflammatory arthritis diagnosis: disentangling the relationship between mental health and arthritis.","volume":"76","author":"Howren","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"zoi250702r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102634","article-title":"Neuropsychiatric prodromes and symptom timings in relation to disease onset and\/or flares in SLE: results from the mixed methods international INSPIRE study.","volume":"73","author":"Sloan","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10","key":"zoi250702r40","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/jnnp-2023-333007","article-title":"Neuroanatomical and prognostic associations of depression in Parkinson\u2019s disease.","volume":"95","author":"Badenoch","year":"2024","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"zoi250702r41","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1177\/13872877241295407","article-title":"Documentation of prodromal features and risk factors of dementia disease in primary care practice.","volume":"102","author":"Michalowsky","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"zoi250702r42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/jnnp-2022-329806","article-title":"Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction.","volume":"94","author":"Menculini","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"zoi250702r43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jpsychores.2017.07.015","article-title":"Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.","volume":"101","author":"Marrie","year":"2017","journal-title":"J Psychosom Res"},{"issue":"12","key":"zoi250702r44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52652","article-title":"Symptoms prior to diagnosis of multiple sclerosis in individuals younger than 18 years.","volume":"7","author":"Akmatov","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi250702r45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neurol.2020.07.018","article-title":"Low back pain in patients with multiple sclerosis: a systematic review and the prevalence in a French multiple sclerosis population.","volume":"177","author":"Massot","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"zoi250702r46","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.754144","article-title":"Development and internal validation of a disability algorithm for multiple sclerosis in administrative data.","volume":"12","author":"Marrie","year":"2021","journal-title":"Front Neurol"},{"issue":"14","key":"zoi250702r47","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1177\/13524585221118677","article-title":"Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.","volume":"28","author":"Meaton","year":"2022","journal-title":"Mult Scler"},{"issue":"4","key":"zoi250702r48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1352458519882282","article-title":"Single Test to Arrive at Multiple Sclerosis (STAR-MS) diagnosis: a prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty.","volume":"26","author":"Clarke","year":"2020","journal-title":"Mult Scler"},{"issue":"9","key":"zoi250702r49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0274565","article-title":"Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: a systematic review and meta-analysis.","volume":"17","author":"Ning","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"zoi250702r50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/13524585221134213","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a systematic review and meta-analysis.","volume":"29","author":"Hegen","year":"2023","journal-title":"Mult Scler"},{"key":"zoi250702r51","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101009","article-title":"Fluid biomarkers in multiple sclerosis: from current to future applications.","volume":"44","author":"Di Filippo","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"zoi250702r22","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780190933692.001.0001","volume-title":"The CDC Field Epidemiology Manual","author":"Rasmussen","year":"2019"},{"key":"zoi250702r18","unstructured":"Statistics Canada. Health Indicators 2013. Canadian Institute for Health Information. 2013. Accessed July 14, 2024. https:\/\/www.cihi.ca\/sites\/default\/files\/document\/health-indicators-2013-en.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837128\/ruizalguer_2025_oi_250702_1755784662.72691.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:00:27Z","timestamp":1756220427000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.24635","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}